Overview
Recurrent upper respiratory tract infections (URTIs) involve frequent episodes of pharyngitis, tonsillitis, otitis media, and rhinosinusitis, significantly impacting quality of life, particularly in pediatric populations 1.Diagnosis
Frequent episodes of pharyngotonsillitis or otitis media (≥3 episodes in 6 months) 1.
Consider adenotonsillar tissue analysis via PCR for atypical bacteria like chlamydia and Mycoplasma pneumoniae in cases requiring surgical intervention 2.
Evaluate granulocyte function through chemiluminescence assays to assess immune competence 3.
Assess adenoid size and lymphocyte subpopulations using E- and EAC-rosetting techniques for immunological profiles 4.Management
First-line treatments: No specific pharmacological first-line treatments are strongly recommended across abstracts.
Adjunctive therapies: Herbal compound Imoviral® Junior (containing Echinacea angustifolia, Arabinogalactan, Acerola, Beta-Glucan, and Zinc) may reduce frequency of inflammatory episodes and improve quality of life in pediatric patients 1.
Targeted antibiotic therapy: Consider identification and treatment of atypical bacteria like chlamydia and Mycoplasma pneumoniae in recurrent cases 2.Special Populations
Pediatrics: Herbal compounds like Imoviral® Junior show promise in reducing recurrent infections and improving quality of life 1.
Comorbidities: Altered granulocyte function is prevalent in children with recurrent infections and tonsillar hypertrophy, suggesting immune dysfunction as a key factor 3.Key Recommendations
Evaluate and consider herbal immunostimulants such as Imoviral® Junior for pediatric patients with recurrent URTIs to potentially reduce infection frequency and enhance quality of life (Evidence: Moderate) 1.
Investigate adenoid and tonsillar tissue for atypical bacteria like chlamydia and Mycoplasma pneumoniae in children requiring surgical intervention for recurrent infections (Evidence: Moderate) 2.
Assess granulocyte function in children with recurrent URTIs to identify immune dysfunction, guiding further management (Evidence: Weak) 3.References
1 Minetti AM, Forti S, Tassone G, Torretta S, Pignataro L. Efficacy of complex herbal compound of Echinacea angustifolia (Imoviral® Junior) in recurrent upper respiratory tract infections during pediatric age: preliminary results. Minerva pediatrica 2011. link
2 Piacentini GL, Peroni DG, Blasi F, Pescollderungg L, Goller P, Gallmetzer L et al.. Atypical bacteria in adenoids and tonsils of children requiring adenotonsillectomy. Acta oto-laryngologica 2010. link
3 Kowalska M, Kowalska H, Zawadzka-Głos L, Debska M, Szerszeń E, Chmielik M et al.. Dysfunction of peripheral blood granulocyte oxidative metabolism in children with recurrent upper respiratory tract infections. International journal of pediatric otorhinolaryngology 2003. link00402-0)
4 Yamaguchi T, Isago H, Ara H, Kataura A. Subpopulation of adenoidal lymphocytes of recurrent infection in the upper respiratory tract. International journal of pediatric otorhinolaryngology 1980. link90015-4)